Ebola Outbreak Funding Slashed: US Implements Strategic Responses in Africa
The funding pledges to combat the Ebola outbreak in Africa have been significantly reduced, according to the Africa CDC. The U.S. has taken proactive measures by establishing a quarantine facility in Kenya to prevent the spread of Ebola within its borders. Concurrently, WHO is prioritizing experimental treatments and vaccines for the Bundibugyo strain.
Funding pledges aimed at tackling the Ebola outbreak in Africa have nearly been cut in half since Monday. According to the Africa CDC, this reduction comes as the World Health Organization has declared the outbreak of the rare Bundibugyo strain in Congo and Uganda as a public health emergency of international concern.
In response to the escalating situation, the U.S. is setting up a quarantine facility in Kenya for Americans potentially exposed to Ebola. This measure is part of U.S. efforts to keep Ebola cases out of the country. The move marks a departure from past practices and aligns with broader public health strategies.
The World Health Organization has identified three experimental treatments—including those from Mapp Biopharmaceutical and Gilead Sciences—that should be tested in clinical trials to combat the Bundibugyo strain. This is part of a global push to develop effective medical responses amid the ongoing health crisis.
(With inputs from agencies.)
Google News